Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

AGA affects many, progresses differently, and early treatment is crucial.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Omega-6 fats in certain cells boost male hormone production.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Analog 23 is a promising compound for prostate cancer treatment.

Balding and low testosterone increase risk of urinary stones.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Alopecia should be treated as a medical condition because it may increase the risk of serious diseases and psychological issues.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Finasteride may cause breast enlargement, low testosterone a risk factor.